BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 31313952)

  • 1. Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2.
    Sandoval PJ; Morales M; Secomb TW; Wright SH
    Am J Physiol Renal Physiol; 2019 Sep; 317(3):F720-F734. PubMed ID: 31313952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of a Biguanide Scaffold Enhances Drug Uptake by Organic Cation Transporters 1 and 2.
    Obianom ON; Coutinho AL; Yang W; Yang H; Xue F; Shu Y
    Mol Pharm; 2017 Aug; 14(8):2726-2739. PubMed ID: 28699756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family.
    Parvez MM; Kaisar N; Shin HJ; Jung JA; Shin JG
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6558-6567. PubMed ID: 27550354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 7-ketocholesterol incorporation on substrate binding affinity and turnover rate of the organic cation transporter 2 (OCT2).
    Xiu F; Console L; Indiveri C; Su S; Wang T; Visentin M
    Biochem Pharmacol; 2024 Feb; 220():116017. PubMed ID: 38176620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional significance of conserved cysteines in the human organic cation transporter 2.
    Pelis RM; Dangprapai Y; Cheng Y; Zhang X; Terpstra J; Wright SH
    Am J Physiol Renal Physiol; 2012 Jul; 303(2):F313-20. PubMed ID: 22573376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of ALK Inhibitors with Polyspecific Organic Cation Transporters and the Impact of Substrate-Dependent Inhibition on the Prediction of Drug-Drug Interactions.
    Tsang YP; López Quiñones AJ; Vieira LS; Wang J
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel.
    Boxberger KH; Hagenbuch B; Lampe JN
    Biochem Pharmacol; 2018 Oct; 156():371-384. PubMed ID: 30138624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of OCT2-mediated drug-drug interactions between ulotaront and metformin in subjects with schizophrenia.
    Xiao G; Tsukada H; Chen YL; Shi L; Hopkins SC; Galluppi GR
    Pharmacol Res Perspect; 2024 Apr; 12(2):e1191. PubMed ID: 38527949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Models as Framework for Understanding Biomarker Disposition: Prediction of Creatinine-Drug Interactions.
    Scotcher D; Arya V; Yang X; Zhao P; Zhang L; Huang SM; Rostami-Hodjegan A; Galetin A
    CPT Pharmacometrics Syst Pharmacol; 2020 May; 9(5):282-293. PubMed ID: 32410382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Membrane Cholesterol Regulates the Allosteric Binding of 1-Methyl-4-Phenylpyridinium to Organic Cation Transporter 2 (SLC22A2).
    Hörmann S; Gai Z; Kullak-Ublick GA; Visentin M
    J Pharmacol Exp Ther; 2020 Jan; 372(1):46-53. PubMed ID: 31624079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.
    Yin J; Wagner DJ; Prasad B; Isoherranen N; Thummel KE; Wang J
    Am J Physiol Renal Physiol; 2019 Oct; 317(4):F805-F814. PubMed ID: 31322418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and cellular physiology of organic cation transporter 2.
    Wright SH
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1669-F1679. PubMed ID: 31682169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs.
    George B; Wen X; Jaimes EA; Joy MS; Aleksunes LM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent Regulation of OCT and MATE Drug Transporters by Cadmium Exposure.
    Yang H; Zhou S; Guo D; Obianom ON; Li Q; Shu Y
    Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33924306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning Models Identify New Inhibitors for Human OATP1B1.
    Lane TR; Urbina F; Zhang X; Fye M; Gerlach J; Wright SH; Ekins S
    Mol Pharm; 2022 Nov; 19(11):4320-4332. PubMed ID: 36269563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel method for kinetic analysis applied to transport by the uniporter OCT2.
    Wright SH; Secomb TW
    Am J Physiol Renal Physiol; 2022 Sep; 323(3):F370-F387. PubMed ID: 35862650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier.
    Hau RK; Tash JS; Georg GI; Wright SH; Cherrington NJ
    J Pharmacol Exp Ther; 2022 Sep; 382(3):299-312. PubMed ID: 35779861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport Turnover Rates for Human OCT2 and MATE1 Expressed in Chinese Hamster Ovary Cells.
    Zhang X; Wright SH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic Compounds with SARS-CoV-2 Antiviral Activity and Their Interaction with Organic Cation Transporter/Multidrug and Toxin Extruder Secretory Transporters.
    Martinez-Guerrero L; Zhang X; Zorn KM; Ekins S; Wright SH
    J Pharmacol Exp Ther; 2021 Oct; 379(1):96-107. PubMed ID: 34253645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation Mechanisms of Expression and Function of Organic Cation Transporter 1.
    Ciarimboli G
    Front Pharmacol; 2020; 11():607613. PubMed ID: 33732143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.